{"transactions":[{"id":722577,"issuer":{"id":2452,"kind":"organization","name":"Septerna, Inc.","symbol":"SEPN"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-30T23:00:07.000Z","date":"2026-06-26","kind":"grant","planned":false,"acquired":true,"shares":11260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option vest in full upon the earlier of (i) June 26, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":11260,"derivative":{"exercise_price":37.34,"expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":11260},"source":{"system":"sec-edgar","filing":"0001193125-26-291052","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000119312526291052/ownership.xml","form_type":"4"}},{"id":1031077,"issuer":{"id":2452,"kind":"organization","name":"Septerna, Inc.","symbol":"SEPN"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-29T20:59:05.000Z","date":"2025-09-25","kind":"grant","planned":false,"acquired":true,"shares":33246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to such option shall vest and become exercisable in substantially equal monthly installments on each monthly anniversary of September 25, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":33246,"derivative":{"exercise_price":16.75,"expiration_date":"2035-09-24","underlying":"Common Stock","underlying_shares":33246},"source":{"system":"sec-edgar","filing":"0001193125-25-223384","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000119312525223384/ownership.xml","form_type":"4"}},{"id":1152400,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-12T20:50:03.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an option initially granted to the Reporting Person on February 25, 2024, a portion of which shares underlying this option shall vest upon the achievement of certain performance milestones. On May 8, 2025, the board of directors of the Issuer determined that one of the performance milestone conditions was achieved, resulting in the vesting of 100,000 shares."}],"balance_after":300000,"derivative":{"exercise_price":8.32,"expiration_date":"2034-02-25","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001894562-25-000019","document":"wk-form4_1747082995.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456225000019/wk-form4_1747082995.xml","form_type":"4"}},{"id":1229583,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-04T21:15:09.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of February 28, 2025, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":500000,"derivative":{"exercise_price":2.52,"expiration_date":"2035-02-28","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001894562-25-000014","document":"wk-form4_1741122898.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456225000014/wk-form4_1741122898.xml","form_type":"4"}},{"id":1339187,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-09T23:23:08.000Z","date":"2024-12-05","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an option initially granted to the Reporting Person on February 25, 2024, a portion of which shares underlying this option shall vest on February 25, 2025 upon the achievement of certain performance milestones. On December 5, 2024, the board of directors of the Issuer determined that one of the performance milestone conditions was achieved. As a result, the shares underlying this option shall vest on February 25, 2025, subject to the Reporting Person's continued service through such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":8.32,"expiration_date":"2034-02-25","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001894562-24-000049","document":"wk-form4_1733786581.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456224000049/wk-form4_1733786581.xml","form_type":"4"}},{"id":1388181,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-10-10T20:29:11.000Z","date":"2024-10-08","kind":"gift","planned":false,"acquired":true,"shares":226925,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 8, 2024, for bona fide estate planning purposes, the Reporting Person's spouse transferred 226,925 shares of Issuer common stock to a family trust for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by a trust for which certain of the Reporting Person's family member is a trustee. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose."}],"balance_after":682259,"source":{"system":"sec-edgar","filing":"0001894562-24-000043","document":"wk-form4_1728592144.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456224000043/wk-form4_1728592144.xml","form_type":"4"}},{"id":1388180,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-10-10T20:29:11.000Z","date":"2024-10-08","kind":"gift","planned":false,"acquired":false,"shares":226925,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 8, 2024, for bona fide estate planning purposes, the Reporting Person's spouse transferred 226,925 shares of Issuer common stock to a family trust for no consideration."}],"balance_after":50241,"source":{"system":"sec-edgar","filing":"0001894562-24-000043","document":"wk-form4_1728592144.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456224000043/wk-form4_1728592144.xml","form_type":"4"}},{"id":1487170,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-06-07T20:18:08.000Z","date":"2024-06-05","kind":"gift","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 5, 2024, for bona fide estate planning purposes, the Reporting Person transferred 250,000 shares of Issuer common stock to his spouse for no consideration."}],"balance_after":277166,"source":{"system":"sec-edgar","filing":"0001894562-24-000026","document":"wk-form4_1717791477.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456224000026/wk-form4_1717791477.xml","form_type":"4"}},{"id":1487169,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-06-07T20:18:08.000Z","date":"2024-06-05","kind":"gift","planned":false,"acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 5, 2024, for bona fide estate planning purposes, the Reporting Person transferred 250,000 shares of Issuer common stock to his spouse for no consideration."}],"balance_after":2310837,"source":{"system":"sec-edgar","filing":"0001894562-24-000026","document":"wk-form4_1717791477.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456224000026/wk-form4_1717791477.xml","form_type":"4"}},{"id":1616265,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-27T14:35:21.000Z","date":"2024-02-25","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of February 25, 2024, subject to the Reporting Person's continued service on each such vesting date. Not reported herein are performance-based options awarded to the Reporting Person on the same transaction date, which vest upon the achievement of certain performance criteria. As of the transaction date, the performance criteria for such performance-based options have not yet been satisfied."}],"balance_after":100000,"derivative":{"exercise_price":8.32,"expiration_date":"2034-02-25","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001894562-24-000016","document":"wk-form4_1709044527.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456224000016/wk-form4_1709044527.xml","form_type":"4"}},{"id":1742531,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-11-15T01:11:51.000Z","date":"2023-11-11","kind":"gift","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On November 11, 2023, the Reporting Person's spouse transferred 5,000 shares of Issuer common stock to the Coolidge GST Trust-2022 for no consideration."}],"balance_after":27166,"source":{"system":"sec-edgar","filing":"0001894562-23-000034","document":"wk-form4_1700010693.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456223000034/wk-form4_1700010693.xml","form_type":"4"}},{"id":1742530,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-11-15T01:11:51.000Z","date":"2023-11-11","kind":"gift","planned":false,"acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 11, 2023, the Reporting Person transferred 7,500 shares of Issuer common stock to the Gottesdiener Family GST Trust for no consideration."}],"balance_after":2560837,"source":{"system":"sec-edgar","filing":"0001894562-23-000034","document":"wk-form4_1700010693.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456223000034/wk-form4_1700010693.xml","form_type":"4"}},{"id":1743624,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:43:13.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2966,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":72.74,"underlying":"Common Stock","underlying_shares":2966},"source":{"system":"sec-edgar","filing":"0001104659-23-117102","document":"tm2330435-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117102/tm2330435-9_4seq1.xml","form_type":"4"}},{"id":1743623,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:43:13.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2174,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":82.25,"underlying":"Common Stock","underlying_shares":2174},"source":{"system":"sec-edgar","filing":"0001104659-23-117102","document":"tm2330435-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117102/tm2330435-9_4seq1.xml","form_type":"4"}},{"id":1743622,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:43:13.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2748,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":85.12,"underlying":"Common Stock","underlying_shares":2748},"source":{"system":"sec-edgar","filing":"0001104659-23-117102","document":"tm2330435-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117102/tm2330435-9_4seq1.xml","form_type":"4"}},{"id":1743621,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:43:13.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2036,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":122.01,"underlying":"Common Stock","underlying_shares":2036},"source":{"system":"sec-edgar","filing":"0001104659-23-117102","document":"tm2330435-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117102/tm2330435-9_4seq1.xml","form_type":"4"}},{"id":1743620,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:43:13.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3196,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":145.22,"underlying":"Common Stock","underlying_shares":3196},"source":{"system":"sec-edgar","filing":"0001104659-23-117102","document":"tm2330435-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117102/tm2330435-9_4seq1.xml","form_type":"4"}},{"id":1743619,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:43:13.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12547,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":9.17,"underlying":"Common Stock","underlying_shares":12547},"source":{"system":"sec-edgar","filing":"0001104659-23-117102","document":"tm2330435-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117102/tm2330435-9_4seq1.xml","form_type":"4"}},{"id":1743618,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:43:13.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12790,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":16.82,"underlying":"Common Stock","underlying_shares":12790},"source":{"system":"sec-edgar","filing":"0001104659-23-117102","document":"tm2330435-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117102/tm2330435-9_4seq1.xml","form_type":"4"}},{"id":1743617,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:43:13.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12089,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":17.08,"underlying":"Common Stock","underlying_shares":12089},"source":{"system":"sec-edgar","filing":"0001104659-23-117102","document":"tm2330435-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117102/tm2330435-9_4seq1.xml","form_type":"4"}},{"id":1743616,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-13T14:43:13.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8111,"price":19,"value":154109.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represented a contingent right to receive one share of Company Common Stock upon vesting of the RSU."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each RSU that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the contingent right to receive a cash payment (without interest and subject to any applicable tax withholding) equal to (A) the Offer Price, multiplied by (B) the number of shares of Company Common Stock subject to such RSU. Such payment right will vest and become payable in accordance with vesting schedule (including any vesting acceleration provisions) that applied to the corresponding portion of the applicable RSUs immediately prior to the Effective Time."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-23-117102","document":"tm2330435-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117102/tm2330435-9_4seq1.xml","form_type":"4"}},{"id":1743615,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-13T14:43:13.000Z","date":"2023-11-08","kind":"other","planned":false,"acquired":false,"shares":24719,"price":19,"value":469661.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of September 26, 2023, among the Issuer, Alfasigma S.p.A. (\"Alfasigma\"), and Interstellar Acquisition Inc., a wholly owned subsidiary of Alfasigma (\"Purchaser\"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (\"Company Common Stock\") and thereafter merged with and into the Issuer, effective as of November 8, 2023 (the \"Effective Time\"). At the Effective Time, each issued and outstanding share of Company Common Stock was cancelled and converted into the right to receive $19.00 in cash (the \"Offer Price\") without interest and subject to applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-23-117102","document":"tm2330435-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117102/tm2330435-9_4seq1.xml","form_type":"4"}},{"id":1877852,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-05-25T20:40:13.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":12547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the options subject to the award shall vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's 2024 Annual Meeting of Stockholders."}],"balance_after":12547,"derivative":{"exercise_price":9.17,"expiration_date":"2033-05-24","underlying":"Common Stock","underlying_shares":12547},"source":{"system":"sec-edgar","filing":"0001104659-23-064844","document":"tm2317083-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923064844/tm2317083-7_4seq1.xml","form_type":"4"}},{"id":1877851,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-25T20:40:13.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":8111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. All of the shares subject to the award shall vest on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's 2024 Annual Meeting of Stockholders."}],"balance_after":32830,"source":{"system":"sec-edgar","filing":"0001104659-23-064844","document":"tm2317083-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923064844/tm2317083-7_4seq1.xml","form_type":"4"}},{"id":1929024,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-05T00:22:42.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":497738,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 31, 2023, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":497738,"derivative":{"exercise_price":12.3,"expiration_date":"2033-03-31","underlying":"Common Stock","underlying_shares":497738},"source":{"system":"sec-edgar","filing":"0001894562-23-000003","document":"wf-form4_168065415301251.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456223000003/wf-form4_168065415301251.xml","form_type":"4"}},{"id":2253046,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2022-05-27T16:16:58.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":12790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the options subject to the award shall vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's 2023 Annual Meeting of Stockholders."}],"balance_after":12790,"derivative":{"exercise_price":16.82,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":12790},"source":{"system":"sec-edgar","filing":"0001104659-22-065902","document":"tm2217184-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465922065902/tm2217184-2_4seq1.xml","form_type":"4"}},{"id":2253045,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-27T16:16:58.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":7737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. All of the shares subject to the award shall vest on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's 2023 Annual Meeting of Stockholders."}],"balance_after":24719,"source":{"system":"sec-edgar","filing":"0001104659-22-065902","document":"tm2217184-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465922065902/tm2217184-2_4seq1.xml","form_type":"4"}},{"id":2688733,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2021-06-01T19:02:25.000Z","date":"2021-05-27","kind":"grant","acquired":true,"shares":12089,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the options subject to the award shall vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's 2022 Annual Meeting of Stockholders."}],"balance_after":12089,"derivative":{"exercise_price":17.08,"expiration_date":"2031-05-27","underlying":"Common Stock","underlying_shares":12089},"source":{"system":"sec-edgar","filing":"0001104659-21-075219","document":"tm2118118-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921075219/tm2118118-6_4seq1.xml","form_type":"4"}},{"id":2688732,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-01T19:02:25.000Z","date":"2021-05-27","kind":"grant","acquired":true,"shares":7029,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. All of the shares subject to the award shall vest on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's 2022 Annual Meeting of Stockholders."}],"balance_after":16982,"source":{"system":"sec-edgar","filing":"0001104659-21-075219","document":"tm2118118-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921075219/tm2118118-6_4seq1.xml","form_type":"4"}},{"id":3128898,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2020-06-01T19:04:23.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":2966,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the options subject to the award shall vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's 2021 Annual Meeting of Stockholders."}],"balance_after":2966,"derivative":{"exercise_price":72.74,"expiration_date":"2030-05-28","underlying":"Common Stock","underlying_shares":2966},"source":{"system":"sec-edgar","filing":"0001104659-20-068535","document":"tm2021501d6_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920068535/tm2021501d6_4.xml","form_type":"4"}},{"id":3128897,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-01T19:04:23.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":1595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. All of the shares subject to the award shall vest on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's 2021 Annual Meeting of Stockholders."}],"balance_after":9953,"source":{"system":"sec-edgar","filing":"0001104659-20-068535","document":"tm2021501d6_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920068535/tm2021501d6_4.xml","form_type":"4"}},{"id":3214967,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-03-11T20:01:46.000Z","date":"2020-03-09","kind":"exercise","acquired":false,"shares":3408,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in 48 successive, equal monthly installments measured from January 6, 2017."}],"balance_after":207877,"derivative":{"exercise_price":6.14,"expiration_date":"2027-04-04","underlying":"Common Stock","underlying_shares":3408},"source":{"system":"sec-edgar","filing":"0001104659-20-031918","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465920031918/a4.xml","form_type":"4"}},{"id":3214966,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2020-03-11T20:01:46.000Z","date":"2020-03-09","kind":"exercise","acquired":true,"shares":3408,"price":6.14,"value":20925.12,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 559 shares acquired under the issuer's 2017 Employee Stock Purchase Plan on March 2, 2020."}],"balance_after":558250,"source":{"system":"sec-edgar","filing":"0001104659-20-031918","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465920031918/a4.xml","form_type":"4"}},{"id":3276183,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-02-12T21:00:37.000Z","date":"2020-02-10","kind":"exercise","acquired":false,"shares":6816,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in 48 successive, equal monthly installments measured from January 6, 2017."}],"balance_after":211286,"derivative":{"exercise_price":6.14,"expiration_date":"2027-04-04","underlying":"Common Stock","underlying_shares":6816},"source":{"system":"sec-edgar","filing":"0001104659-20-019193","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465920019193/a4.xml","form_type":"4"}},{"id":3276182,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2020-02-12T21:00:37.000Z","date":"2020-02-10","kind":"exercise","acquired":true,"shares":6816,"price":6.14,"value":41850.24,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 553 shares acquired under the issuer's 2017 Employee stock purchase plan on September 3, 2019."}],"balance_after":554283,"source":{"system":"sec-edgar","filing":"0001104659-20-019193","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465920019193/a4.xml","form_type":"4"}},{"id":3313058,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-01-10T21:01:42.000Z","date":"2020-01-08","kind":"exercise","acquired":false,"shares":33072,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable in 48 successive, equal monthly installments measured from August 3, 2015."}],"balance_after":84208,"derivative":{"exercise_price":4.59,"expiration_date":"2025-11-16","underlying":"Common Stock","underlying_shares":33072},"source":{"system":"sec-edgar","filing":"0001104659-20-003024","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465920003024/a4.xml","form_type":"4"}},{"id":3313057,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2020-01-10T21:01:42.000Z","date":"2020-01-08","kind":"exercise","acquired":true,"shares":33072,"price":4.59,"value":151800.48,"ownership":{"direct":true},"balance_after":546914,"source":{"system":"sec-edgar","filing":"0001104659-20-003024","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465920003024/a4.xml","form_type":"4"}},{"id":3459589,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-07-17T20:11:35.000Z","date":"2019-07-16","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable in 48 successive, equal monthly installments measured from August 3, 2015."}],"balance_after":117280,"derivative":{"exercise_price":4.59,"expiration_date":"2025-11-16","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001104659-19-040756","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465919040756/a4.xml","form_type":"4"}},{"id":3459588,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-07-17T20:11:35.000Z","date":"2019-07-16","kind":"exercise","acquired":true,"shares":7500,"price":4.59,"value":34425.0,"ownership":{"direct":true},"balance_after":513842,"source":{"system":"sec-edgar","filing":"0001104659-19-040756","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465919040756/a4.xml","form_type":"4"}},{"id":3481148,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2019-06-21T19:01:37.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":2174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the options subject to the award shall vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's 2020 Annual Meeting of Stockholders."}],"balance_after":2174,"derivative":{"exercise_price":82.25,"expiration_date":"2029-06-20","underlying":"Common Stock","underlying_shares":2174},"source":{"system":"sec-edgar","filing":"0001144204-19-031957","document":"tv524023_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419031957/tv524023_4.xml","form_type":"4"}},{"id":3481147,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-21T19:01:37.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":1570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. All of the shares subject to the award shall vest on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's 2020 Annual Meeting of Stockholders."}],"balance_after":8358,"source":{"system":"sec-edgar","filing":"0001144204-19-031957","document":"tv524023_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419031957/tv524023_4.xml","form_type":"4"}},{"id":3585668,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2019-03-19T20:25:08.000Z","date":"2019-03-18","kind":"sale","acquired":false,"shares":2329,"price":30.27,"value":70498.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On March 18, 2019, Mr. Gottesdiener sold 2,329 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $30.09 to $30.50, inclusive; the price reported above reflects the weighted average sale price. Mr. Gottesdiener hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":506342,"source":{"system":"sec-edgar","filing":"0001104659-19-015985","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465919015985/a4.xml","form_type":"4"}},{"id":3585667,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2019-03-19T20:25:08.000Z","date":"2019-03-15","kind":"sale","acquired":false,"shares":7961,"price":30.04,"value":239148.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 15, 2019, Mr. Gottesdiener sold 7,961 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $30.00 to $30.20, inclusive; the price reported above reflects the weighted average sale price. Mr. Gottesdiener hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":508671,"source":{"system":"sec-edgar","filing":"0001104659-19-015985","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465919015985/a4.xml","form_type":"4"}},{"id":3592292,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2019-03-15T20:01:38.000Z","date":"2019-03-14","kind":"sale","acquired":false,"shares":1506,"price":30.05,"value":45255.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On March 14, 2019, Mr. Gottesdiener sold 1,506 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $30.00 to $30.50, inclusive; the price reported above reflects the weighted average sale price. Mr. Gottesdiener hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":516632,"source":{"system":"sec-edgar","filing":"0001104659-19-015281","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465919015281/a4.xml","form_type":"4"}},{"id":3592291,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2019-03-15T20:01:38.000Z","date":"2019-03-13","kind":"sale","acquired":false,"shares":7782,"price":30.06,"value":233926.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 13, 2019, Mr. Gottesdiener sold 7,782 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $30.00 to $30.20, inclusive; the price reported above reflects the weighted average sale price. Mr. Gottesdiener hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 303 shares acquired under the issuer's 2017 Employee Stock Purchase Plan on February 28, 2019."}],"balance_after":518138,"source":{"system":"sec-edgar","filing":"0001104659-19-015281","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465919015281/a4.xml","form_type":"4"}},{"id":3625525,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-02-28T21:01:47.000Z","date":"2019-02-27","kind":"sale","acquired":false,"shares":1814,"price":30.01,"value":54438.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On February 27, 2019, Mr. Gottesdiener sold 1,814 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $30.00 to $30.09, inclusive; the price reported above reflects the weighted average sale price. Mr. Gottesdiener hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":525617,"source":{"system":"sec-edgar","filing":"0001104659-19-011530","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465919011530/a4.xml","form_type":"4"}},{"id":3625524,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-02-28T21:01:47.000Z","date":"2019-02-26","kind":"sale","acquired":false,"shares":635,"price":30.13,"value":19132.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 26, 2019, Mr. Gottesdiener sold 635 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $30.01 to $30.14, inclusive; the price reported above reflects the weighted average sale price. Mr. Gottesdiener hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":527431,"source":{"system":"sec-edgar","filing":"0001104659-19-011530","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465919011530/a4.xml","form_type":"4"}},{"id":3644616,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-02-20T21:01:17.000Z","date":"2019-02-19","kind":"sale","acquired":false,"shares":918,"price":30.05,"value":27585.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On February 19, 2019, Mr. Gottesdiener sold 918 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":528066,"source":{"system":"sec-edgar","filing":"0001104659-19-009555","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465919009555/a4.xml","form_type":"4"}},{"id":3644615,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-02-20T21:01:17.000Z","date":"2019-02-15","kind":"sale","acquired":false,"shares":12002,"price":30.02,"value":360300.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 15, 2019, Mr. Gottesdiener sold 12,002 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $30.00 to $30.18, inclusive; the price reported above reflects the weighted average sale price. Mr. Gottesdiener hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":528984,"source":{"system":"sec-edgar","filing":"0001104659-19-009555","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465919009555/a4.xml","form_type":"4"}},{"id":3653115,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-15T21:09:51.000Z","date":"2019-02-13","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on February 13, 2019 and the shares underlying this option vest in sixteen equal quarterly installments beginning on May 13, 2019."}],"balance_after":225000,"derivative":{"exercise_price":29.78,"expiration_date":"2029-02-12","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001104659-19-009043","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465919009043/a4.xml","form_type":"4"}},{"id":3653114,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-02-15T21:09:51.000Z","date":"2019-02-13","kind":"sale","acquired":false,"shares":3934,"price":30,"value":118020.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 13, 2019, Mr. Gottesdiener sold 3,934 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $30.00 to $30.03, inclusive; the price reported above reflects the weighted average sale price. Mr. Gottesdiener hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":540986,"source":{"system":"sec-edgar","filing":"0001104659-19-009043","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465919009043/a4.xml","form_type":"4"}},{"id":3687722,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-01-24T21:03:51.000Z","date":"2019-01-23","kind":"sale","acquired":false,"shares":105,"price":30.21,"value":3172.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On January 23, 2019, Mr. Gottesdiener sold 105 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":544920,"source":{"system":"sec-edgar","filing":"0001104659-19-003144","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465919003144/a4.xml","form_type":"4"}},{"id":3687721,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-01-24T21:03:51.000Z","date":"2019-01-22","kind":"sale","acquired":false,"shares":15674,"price":30.05,"value":471003.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 22, 2019, Mr. Gottesdiener sold 15,674 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $30.00 to $30.63, inclusive; the price reported above reflects the weighted average sale price. Mr. Gottesdiener hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":545025,"source":{"system":"sec-edgar","filing":"0001104659-19-003144","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465919003144/a4.xml","form_type":"4"}},{"id":3690422,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2019-01-22T21:07:05.000Z","date":"2019-01-18","kind":"sale","acquired":false,"shares":10115,"price":30.01,"value":303551.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 18, 2019, Mr. Gottesdiener sold 10,115 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $30.00 to $30.25, inclusive; the price reported above reflects the weighted average sale price. Mr. Gottesdiener hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":560699,"source":{"system":"sec-edgar","filing":"0001104659-19-002735","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465919002735/a4.xml","form_type":"4"}},{"id":3692529,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2019-01-17T23:13:44.000Z","date":"2019-01-16","kind":"sale","acquired":false,"shares":662,"price":30,"value":19860.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 16, 2019, Mr. Gottesdiener sold 662 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $30.00 to $30.02, inclusive; the price reported above reflects the weighted average sale price. Mr. Gottesdiener hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":570814,"source":{"system":"sec-edgar","filing":"0001104659-19-002328","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465919002328/a4.xml","form_type":"4"}},{"id":3740675,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2018-12-06T21:03:39.000Z","date":"2018-12-03","kind":"sale","acquired":false,"shares":563,"price":30,"value":16890.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 3, 2018, Mr. Gottesdiener sold 563 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":571476,"source":{"system":"sec-edgar","filing":"0001104659-18-071680","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465918071680/a4.xml","form_type":"4"}},{"id":3772232,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2018-11-06T22:21:49.000Z","date":"2018-11-02","kind":"sale","acquired":false,"shares":16500,"price":30.08,"value":496320.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 2, 2018, Mr. Gottesdiener sold 16,500 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $30.00 to $30.28, inclusive; the price reported above reflects the weighted average sale price. Mr. Gottesdiener hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":572039,"source":{"system":"sec-edgar","filing":"0001104659-18-066382","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465918066382/a4.xml","form_type":"4"}},{"id":3884850,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2018-06-22T17:01:21.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":2748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the shares subject to the award shall vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's 2019 Annual Meeting of Stockholders."}],"balance_after":2748,"derivative":{"exercise_price":85.12,"expiration_date":"2028-06-20","underlying":"Common Stock","underlying_shares":2748},"source":{"system":"sec-edgar","filing":"0001144204-18-035417","document":"tv496984_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418035417/tv496984_4.xml","form_type":"4"}},{"id":3884849,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-22T17:01:21.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":1787,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. All of the shares subject to the award shall vest on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's 2019 Annual Meeting of Stockholders."}],"balance_after":6788,"source":{"system":"sec-edgar","filing":"0001144204-18-035417","document":"tv496984_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418035417/tv496984_4.xml","form_type":"4"}},{"id":3938332,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"C.E.O. and President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-05-10T20:08:40.000Z","date":"2018-05-09","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable in 48 successive, equal monthly installments measured from August 3, 2015."}],"balance_after":124780,"derivative":{"exercise_price":4.59,"expiration_date":"2025-11-16","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001104659-18-032155","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465918032155/a4.xml","form_type":"4"}},{"id":3938331,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"C.E.O. and President"}}],"security":"Common Stock","published_at":"2018-05-10T20:08:40.000Z","date":"2018-05-09","kind":"exercise","acquired":true,"shares":3000,"price":4.59,"value":13770.0,"ownership":{"direct":true},"balance_after":588539,"source":{"system":"sec-edgar","filing":"0001104659-18-032155","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465918032155/a4.xml","form_type":"4"}},{"id":3966909,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-09T19:37:17.000Z","date":"2018-04-09","kind":"purchase","acquired":true,"shares":1171,"price":64,"value":74944.0,"ownership":{"direct":true},"balance_after":5001,"source":{"system":"sec-edgar","filing":"0001144204-18-019837","document":"tv490676_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418019837/tv490676_form4.xml","form_type":"4"}},{"id":4051156,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-02-16T21:03:26.000Z","date":"2018-02-14","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 14, 2018 and the shares underlying this option vest in sixteen equal quarterly installments."}],"balance_after":175000,"derivative":{"exercise_price":25.79,"expiration_date":"2028-02-13","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001104659-18-010369","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465918010369/a4.xml","form_type":"4"}},{"id":4188653,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Series A Convertible Preferred Stock","published_at":"2017-10-10T20:23:40.000Z","date":"2017-10-10","kind":"exercise","acquired":false,"shares":27262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of the Issuer's series A convertible preferred stock (the \"Series A Preferred\") converted into the Issuer's common stock on a 9.17-for-one basis without payment or consideration.  The Series A Preferred had no expiration date."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the number of shares of Series A Preferred held by the Reporting Person on an as-converted to common stock basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of the Issuer's series A convertible preferred stock (the \"Series A Preferred\") converted into the Issuer's common stock on a 9.17-for-one basis without payment or consideration.  The Series A Preferred had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of the Issuer's series A convertible preferred stock (the \"Series A Preferred\") converted into the Issuer's common stock on a 9.17-for-one basis without payment or consideration.  The Series A Preferred had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Reflects the number of shares of Series A Preferred held by the Reporting Person on an as-converted to common stock basis."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":27262},"source":{"system":"sec-edgar","filing":"0001104659-17-061576","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465917061576/a4.xml","form_type":"4"}},{"id":4188652,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2017-10-10T20:23:40.000Z","date":"2017-10-10","kind":"exercise","acquired":true,"shares":27262,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of the Issuer's series A convertible preferred stock (the \"Series A Preferred\") converted into the Issuer's common stock on a 9.17-for-one basis without payment or consideration.  The Series A Preferred had no expiration date."}],"balance_after":585539,"source":{"system":"sec-edgar","filing":"0001104659-17-061576","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615856/000110465917061576/a4.xml","form_type":"4"}},{"id":4270085,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2017-06-29T21:00:06.000Z","date":"2017-06-27","kind":"grant","acquired":true,"shares":2036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The 1,423 shares of restricted stock and the shares of 2,036 shares of common stock underlying the option will each fully vest on the one-year anniversary of the date of grant (the \"Anniversary Date\"), subject to the terms and conditions of the award and the Intercept Pharmaceuticals, Inc. 2012 Equity Incentive Plan (the \"2012 Plan\"); provided, however, if the date of the next subsequent annual meeting of stockholders (starting from the 2018 annual meeting) is held prior to the Anniversary Date in that year, the annual vesting for such year shall occur on the day immediately preceding the date of the annual meeting in such year."}],"balance_after":2036,"derivative":{"exercise_price":122.01,"expiration_date":"2027-06-27","underlying":"Common Stock","underlying_shares":2036},"source":{"system":"sec-edgar","filing":"0001144204-17-035029","document":"v470069_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417035029/v470069_form4.xml","form_type":"4"}},{"id":4270084,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":34408,"kind":"person","name":"Gottesdiener Keith Michael","position":1,"cik":"0001615856","reported_name":"Gottesdiener Keith Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-29T21:00:06.000Z","date":"2017-06-27","kind":"grant","acquired":true,"shares":1423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 1,423 shares of restricted stock and the shares of 2,036 shares of common stock underlying the option will each fully vest on the one-year anniversary of the date of grant (the \"Anniversary Date\"), subject to the terms and conditions of the award and the Intercept Pharmaceuticals, Inc. 2012 Equity Incentive Plan (the \"2012 Plan\"); provided, however, if the date of the next subsequent annual meeting of stockholders (starting from the 2018 annual meeting) is held prior to the Anniversary Date in that year, the annual vesting for such year shall occur on the day immediately preceding the date of the annual meeting in such year."}],"balance_after":3830,"source":{"system":"sec-edgar","filing":"0001144204-17-035029","document":"v470069_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417035029/v470069_form4.xml","form_type":"4"}}]}